Data from the rollout of AstraZeneca's Covid-19 vaccine shows one dose of the shot results in 80 per cent less risk of death from the disease, Public Health England said on Monday.
It also said protection against death from the Pfizer-BioNTech (PFE.N), vaccine rises from approximately 80 per cent after one dose to 97 per cent after two doses in its new analysis.
PHE said the study was the first on protection against mortality from the AstraZeneca vaccine based on data from a real world setting.
The study looked at new symptomatic cases of Covid-19 between December and April and people who died within 28 days of their positive test by vaccination status.
People who had a single dose of AstraZeneca vaccine were 55 per cent protected against death, with a figure of 44 per cent protection for a single dose of Pfizer, compared to unvaccinated people.
"Combined with the protection vaccines offer against becoming a case in the first place, this is equivalent to approximately 80 per cent protection against mortality in individuals vaccinated with a single dose of either vaccine," PHE said in a statement.
Protection against mortality from the Pfizer-BioNTech vaccine improved to 69 per cent for cases who had their second dose at least a week before they tested positive. Combined with the estimated protection from getting COVID-19 to start with, this is equivalent to an estimated 97 per cent protection, PHE said.
Prime Minister Boris Johnson is set to confirm further easing of lockdown restrictions in England on Monday, helped in part by the speed of the country's vaccine rollout.
In another dataset, PHE said that it was estimated that two doses of the Pfizer-BioNTech vaccine reduces the risk of hospitalisation by 93 per cent for the over 80s.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU